Delivery Order SPE2DR25D2001-SPE2DR26FBFL1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,143.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used in military...
- The Defense Logistics Agency awarded a delivery order valued at $20,835.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on October 21, 2025, with completion expected by October 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation supports federal pharmaceutical procurement requirements, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Jardiance is a...
- The Defense Logistics Agency awarded a delivery order valued at $39,850.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 12, 2025, with completion targeted for August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used within military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,954.01 on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price, competitively awarded contract represents a non-set-aside delivery order with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $68,604.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, aligning with the...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $12,586.41 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $7,878.06 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription diabetes medication commonly used to...
- The Defense Logistics Agency awarded a delivery order valued at $19,623.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a commonly prescribed medication for diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- SPE2DR25D2001Indefinite Delivery Contract
- SPE2DR25D2001-SPE2DR26FBFL1Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $60,621.77 for 90 tablets of Jardiance 25 mg on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems, and this order represents a routine pharmaceutical supply transaction under the company's existing contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs worldwide. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet evolving federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.6k | 11/17/25 |